Anti-PTEN antibody (ab31392)

ab31392 has been referenced in 8 publications.

• Chen J  et al. Low expression of phosphatase and tensin homolog in clear-cell renal cell carcinoma contributes to chemoresistance through activating the Akt/HDM2 signaling pathway. Mol Med Rep 12:2622-8 (2015). WB, IHC . PubMed: 25954860
• Yang Z  et al. Phosphorylation and inactivation of PTEN at residues Ser380/Thr382/383 induced by Helicobacter pylori promotes gastric epithelial cell survival through PI3K/Akt pathway. Oncotarget 6:31916-26 (2015). IHC-P ; Human . PubMed: 26376616
• Zeng C  et al. SPOP suppresses tumorigenesis by regulating hedgehog/Gli2 signaling pathway in gastric cancer. J Exp Clin Cancer Res 33:75 (2014). Human . PubMed: 25204354
• Chen MH  et al. Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma. Oncotarget 5:2372-89 (2014). IHC-P ; Human . PubMed: 24796583
• Stik G  et al. The oncogenic microRNA OncomiR-21 overexpressed during Marek's disease lymphomagenesis is transactivated by the viral oncoprotein Meq. J Virol 87:80-93 (2013). PubMed: 23055556
• Liu C  et al. A novel PTEN gene promoter mutation and untypical Cowden syndrome. Chin J Cancer Res 25:306-11 (2013). PubMed: 23825907
• Krohn A  et al. Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer. Am J Pathol 181:401-12 (2012). IHC-P ; Human . PubMed: 22705054
• Fernandez-Marcos PJ  et al. Simultaneous inactivation of Par-4 and PTEN in vivo leads to synergistic NF-kappaB activation and invasive prostate carcinoma. Proc Natl Acad Sci U S A 106:12962-7 (2009). IHC-P ; Mouse . PubMed: 19470463